BetterLife Pharma Inc. (OTCQB:BETRD) (CSE:BETR) CEO Ahmad Doroudian tells Proactive the firm has finalized its rebranding exercise for its wholly-owned subsidiary, BLife Therapeutics, which has been publicly formalized through the launching of its new website.
Doroudian says the company’s name and branding is now more consistent with its intent to become a major player within the biotechnology space. The new website, http://www.blifetherapeutics.com, provides visitors with an overview of the company’s treatment development pipeline, including information on the trial Phases for each of the treatments.
